Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.76B |
| 2 |
Tesla
TSLA
|
+$1.37B |
| 3 |
Amazon
AMZN
|
+$623M |
| 4 |
AbbVie
ABBV
|
+$398M |
| 5 |
Qualcomm
QCOM
|
+$394M |
Top Sells
| 1 |
CELG
Celgene Corp
CELG
|
+$1.54B |
| 2 |
Johnson & Johnson
JNJ
|
+$603M |
| 3 |
Micron Technology
MU
|
+$366M |
| 4 |
Meta Platforms (Facebook)
META
|
+$365M |
| 5 |
UnitedHealth
UNH
|
+$353M |
Sector Composition
| 1 | Healthcare | 21.21% |
| 2 | Technology | 12.91% |
| 3 | Consumer Discretionary | 10.45% |
| 4 | Financials | 8.47% |
| 5 | Industrials | 7.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3276
AquaBounty Technologies
AQB
$4.54M
| $125K | ﹤0.01% |
+2,885
| New | +$125K |
|
3277
Smart Powerr
CREG
$4.59M
| $124K | ﹤0.01% |
4,410
+242
| +6% | +$6.81K |
|
3278
Caledonia Mining Corp
CMCL
$572M
| $123K | ﹤0.01% |
14,656
+168
| +1% | +$1.41K |
|
3279
SPAR Group
SGRP
$27.7M
| $123K | ﹤0.01% |
94,800
+52,800
| +126% | +$68.5K |
|
|
AHPI
3280
DELISTED
Allied Healthcare Products
AHPI
| $123K | ﹤0.01% |
101,082
+3,442
| +4% | +$4.19K |
|
3281
Myomo
MYO
$35.9M
| $122K | ﹤0.01% |
13,464
+4,651
| +53% | +$42.1K |
|
3282
Tandy Leather Factory
TLF
$24.5M
| $122K | ﹤0.01% |
21,400
+1,000
| +5% | +$5.7K |
|
3283
Archrock
AROC
$4.26B
| $121K | ﹤0.01% |
12,100
-168,800
| -93% | -$1.69M |
|
3284
Liquidia Corp
LQDA
$2.42B
| $121K | ﹤0.01% |
28,197
-9,703
| -26% | -$41.6K |
|
3285
Seanergy Maritime Holdings
SHIP
$172M
| $121K | ﹤0.01% |
1,383
-57
| -4% | -$4.99K |
|
|
ATXI
3286
DELISTED
Avenue Therapeutics, Inc. Common Stock
ATXI
| $121K | ﹤0.01% |
+11
| New | +$121K |
|
|
MARK
3287
DELISTED
Remark Holdings, Inc.
MARK
| $121K | ﹤0.01% |
23,571
+2,690
| +13% | +$13.8K |
|
|
BCOM
3288
DELISTED
B Communications Ltd
BCOM
| $121K | ﹤0.01% |
67,516
+4,700
| +7% | +$8.42K |
|
3289
Dyadic International
DYAI
$35.4M
| $120K | ﹤0.01% |
+23,200
| New | +$120K |
|
3290
Cerus
CERS
$245M
| $119K | ﹤0.01% |
+28,266
| New | +$119K |
|
|
EVLO
3291
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
| $119K | ﹤0.01% |
1,460
+735
| +101% | +$59.9K |
|
|
NHLD
3292
DELISTED
National Holdings Corporation
NHLD
| $118K | ﹤0.01% |
46,203
+2,900
| +7% | +$7.41K |
|
3293
CBAK Energy Technology
CBAT
$79.1M
| $118K | ﹤0.01% |
102,766
-12,854
| -11% | -$14.8K |
|
|
JG
3294
Aurora Mobile
JG
$58.7M
| $118K | ﹤0.01% |
2,006
+1,035
| +107% | +$60.9K |
|
3295
VOC Energy
VOC
$45.6M
| $118K | ﹤0.01% |
+25,521
| New | +$118K |
|
|
ACCS
3296
ACCESS Newswire Inc.
ACCS
$41.8M
| $118K | ﹤0.01% |
+10,101
| New | +$118K |
|
3297
TDH Holdings
PETZ
$12M
| $115K | ﹤0.01% |
4,256
-765
| -15% | -$20.7K |
|
|
GSV
3298
DELISTED
Gold Standard Ventures Corp.
GSV
| $114K | ﹤0.01% |
+132,684
| New | +$114K |
|
3299
CLPS Inc
CLPS
$29.1M
| $113K | ﹤0.01% |
22,500
+6,700
| +42% | +$33.6K |
|
3300
Sutro Biopharma
STRO
$82.6M
| $113K | ﹤0.01% |
+10,300
| New | +$113K |
|